Alzheimer's disease is the world's most common neurodegenerative disease, affecting more than 50 million people globally. Alzheimer's disease is also among the most fatal, landing as one of the top ...
Abemaciclib Plus Fulvestrant in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Final Overall Survival Results From MONARCH 2 Women ...
April 2, 2012 — Approval for the new 23-mg dose of the Alzheimer's disease (AD) drug donepezil (Aricept, Eisai) "breached the FDA's own regulatory standard" and has led to "incomplete and distorted ...
July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results